Dihydropyridine calcium channel blockers in the elderly with diabetic nephropathy: Are they safe?

about

Dihydropyridine calcium channel blockers in the elderly with diabetic nephropathy: Are they safe?

Item

http://www.wikidata.org/entity/Q48280239

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Dihydropyridine calcium channe ...... ic nephropathy: Are they safe?

@en

Dihydropyridine calcium channe ...... ic nephropathy: Are they safe?

@nl

type

Item

label

Dihydropyridine calcium channe ...... ic nephropathy: Are they safe?

@en

Dihydropyridine calcium channe ...... ic nephropathy: Are they safe?

@nl

prefLabel

Dihydropyridine calcium channe ...... ic nephropathy: Are they safe?

@en

Dihydropyridine calcium channe ...... ic nephropathy: Are they safe?

@nl

P1476

Dihydropyridine calcium channe ...... ic nephropathy: Are they safe?

@en

P2093

Antonios H Tzamaloukas

http://www.w3.org/2001/XMLSchema#string

Joseph I Shapiro

http://www.w3.org/2001/XMLSchema#string

Sergey Brodsky

http://www.w3.org/2001/XMLSchema#string

P2860

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Effect of calcium channels blockers and inhibitors of the renin-angiotensin system on renal outcomes and mortality in patients suffering from chronic kidney disease: systematic review and meta-analysis.

Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble.

Treatment of hypertension in patients 80 years of age or older.

Effects of T-type calcium channel blockers on renal function and aldosterone in patients with hypertension: a systematic review and meta-analysis.

Deleterious effects of calcium channel blockade on pressure transmission and glomerular injury in rat remnant kidneys.

Comparison of the effects of calcium antagonists and converting enzyme inhibitors on renal function under normal and hypertensive conditions.

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.

P304

203-204

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JCH.13158

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Zeid Khitan

P577

2018-01-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29316147

http://www.w3.org/2001/XMLSchema#string